Preservation of fertility in females treated for cancer

International Journal of Biological Sciences

Volumn 8, Issue 7, 2012, Pages

  Chuai, Yunhai ^a   Xu, Xiaobin ^a   Wang, Aiming ^a  

^a NAVY GENERAL HOSPITAL   (China)

Author keywords

Cancer patient; Females; Fertility Preservation

Indexed keywords

CRYOPRESERVATION; DRUG EFFECT; FEMALE; FEMALE INFERTILITY; HUMAN; METHODOLOGY; NEOPLASM; OVARY; RADIATION EXPOSURE; REPRODUCTIVE PROCEDURE; REVIEW;

CRYOPRESERVATION; FEMALE; FERTILITY PRESERVATION; HUMANS; INFERTILITY, FEMALE; NEOPLASMS; OVARY;

EID: 84866019587     PISSN: 14492288     EISSN: None     Source Type: Journal    
DOI: 10.7150/ijbs.4800     Document Type: Review

References (92)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10-29.
2. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011. CA Cancer J Clin. 2011;61(4):212-36.
3. Jemal A, Murray T, Samuels A, Ghafoor A, Ward E, Thun MJ. Cancer statistics, 2003. CA Cancer J Clin. 2003;53(1):5-26.
4. Siegel R, Desantis C, Virgo K, Stein K, Mariotto A, Smith T, Cooper D, Gansler T, Lerro C, Fedewa S, Lin C, Leach C, Cannady RS, Cho H, Scoppa S, Hachey M, Kirch R, Jemal A, Ward E. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220-41.
5. Jensen JR, Morbeck DE. Fertility Preservation. Mayo Clin Proc. 2011;86(1):45-49.
6. Sonmezer M, Oktay K. Fertility preservation in female patients. Hum Reprod Update. 2004;10:251-266.
7. Fallat ME, Hutter J. Preservation of fertility in pediatric and adolescent patients with cancer. Pediatrics. 2008;121(5):1461-9.
8. Jacqueline SJ, Teresa KW. Preservation of Fertility in Patients with Can-cer. N Engl J Med. 2009;360(9): 902-911.
9. Lee SJ, Schover LR, Partridge AH, et al. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol. 2006;24(18):2917-2931.
10. Noyes N, Knopman JM, Long K, Coletta JM, Abu-Rustum NR. Fertility considerations in the management of gynecologic malignancies. Gynecol Oncol. 2011;120(3):326-33.
11. Jahnukainen K, Ehmcke J, Soder O, Schlatt S. Clinical potential and putative risks of fertility preservation in children utilizing gonadal tissue or germline stem cells. Pediatr Res. 2006;59(2):40-47.
12. Anchan RM, Ginsburg ES. Fertility concerns and preservation in younger women with breast cancer. Crit Rev Oncol Hematol. 2010;74(3):175-92.
13. Lobo RA. Potential options for preservation of fertility in women. N Engl J Med. 2005;353(1):64-73.
14. Derman SG, Seifer DB. In vitro fertilization in the older patient. Curr Womens Health Rep 2003;3(5):375-83.
15. Lobo RA. Menopause and aging. In: Strauss JF3rd, Barbieri RL, editors. Yen & Jaffe's reproductive endocrinology. Philadelphia, PA:Saunders, Elsevier Inc. 2004: 421-52.
16. Bendsen E, Byskov AG, Andersen CY, Westergaard LG. Number of germ cells and somatic cells in human fetal ovaries during the first weeks after sex differentiation. Hum Reprod 2006;21(1):30-5.
17. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF. Acceler-ated disappearance of ovarian follicles in mid-life: implications for fore-casting menopause. Hum Reprod 1992;7(10):1342-6.
18. Gosden R, Nagano M. Preservation of fertility in nature and ART. Re-production 2002;123(1):3-11.
19. McLaren A, Southee D. Entry of mouse embryonic germ cells into meio-sis. Dev Biol. 1997;187(1):107-113.
20. Gougeon A. Regulation of ovarian follicular development in primates: facts and hypotheses. Endocr Rev. 1996;17(2):121-55.
21. Gougeon A. Ovarian follicular growth in humans: ovarian ageing and population of growing follicles. Maturitas. 1998;30(2):137-42.
22. Gougeon A. The biological aspects of risks of infertility due to age: the female side. Rev Epidemiol Sante Publique. 2005; 2:2S37-45.
23. Hubner K, Fuhrmann G, Christenson LK, et al. Derivation of oocytes from mouse embryonic stem cells. Science. 2003;300(5623):1251-1256.
24. Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL. Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 2004;428(6979):145-50.
25. Johnson J, Bagley J, Skaznik-Wikiel M et al. Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and periph-eral blood. Cell. 2005;122(2):303-315.
26. Telfer EE, Gosden RG, Byskov AG, et al. On regenerating the ovary and generating controversy. Cell. 2005;122(6):821-822.
27. Tilly JL, Niikura Y, Rueda BR. The current status of evidence for and against postnatal oogenesis in mammals: a case of ovarian optimism versus pessimism. Biol Reprod. 2009;80(1):2-12.
28. Oktay K, Kan MT, Rosenwaks Z. Recent progress in oocyte and ovarian tissue cryopreservation and transplantation. Curr Opin Obstet Gynecol. 2001;13:263-268.
29. Warne GL, Fairley KF, Hobbs JB and Martin FI. Cyclophosphamide induced ovarian failure. N Engl J Med. 1973;289:1159-1162.
30. Koyama H, Wada T, Nishizawa Y, Iwanaga T and Aoki Y. Cyclophos-phamide-induced ovarian failure and its therapeutic significance in pa-tients with breast cancer. Cancer 1977;39:1403-1409.
31. Fisher B, Sherman B, Rockette H, Redmond C, Margolese R and Fisher ER. 1-phenylalanine mustard (L-PAM) in the management of premeno-pausal patients with primary breast cancer: lack of association of dis-ease-free survival with depression of ovarian function. Cancer 1979;44:847-857.
32. Viviani S, Santoro A, Ragni G, Bonfante V, Bestetti O and Bonadonna G. Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Eur J Cancer Clin Oncol 1985;21:601-605.
33. Mackie EJ, Radford M and Shalet SM. Gonadal function following chemotherapy for childhood Hodgkin's disease. Med Pediatr Oncol. 1996;27:74-78.
34. Blumenfeld Z, Shapiro D, Shteinberg M, Avivi I and Nahir M. Preserva-tion of fertility and ovarian function and minimizing gonadotoxicity in young women with systemic lupus erythematosus treated by chemo-therapy. Lupus. 2000;9:401-405.
35. Meirow D and Nugent D. The effects of radiotherapy and chemotherapy on female reproduction. Hum Reprod Update. 2001;7:535-543.
36. Kenney LB, Laufer MR, Grant FD, Grier H and Diller L. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer. 2001;91:613-621.
37. Meirow D, Lewis H, Nugent D and Epstein M. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool. Hum Re-prod. 1999;14:1903-1907.
38. Jemal A, Siegel R, Ward E, et al. Cancer statistics. CA Cancer J Clin. 2008;58:71-96.
39. Tauchmanova L, Selleri C, Rosa GD, Pagano L, Orio F, Lombardi G, Rotoli B and Colao A. High prevalence of endocrine dysfunction in long-term survivors after allogeneic bone marrow transplantation for hema-tologic diseases. Cancer. 2002;95:1076-1084.
40. Goodwin P, Ennis M, Pritchard K, Trudeau M, Hood N. Risk of meno-pause during the first year after breast cancer diagnosis. J Clin Oncol. 1999;17:2365-9.
41. Tease C and Fisher G. The influence of maternal age on radiation in-duced chromosome aberrations in mouse oocytes. Mutat Res. 1991;262:57-62.
42. Hawkins MM, Smith RA. Pregnancy outcomes in childhood cancer survivors: probable effects of abdominal irradiation. Int J Cancer. 1989;43:399-402.
43. Critchley HO, Bath LE, Wallace WH. Radiation damage to the uter-us-review of the effects of treatment of childhood cancer. Hum Fertil (Camb) 2002;5:61-6.
44. Covens A, Shaw P, Murphy J, et al. Is radical trachelectomy a safe alter-native to radical hysterectomy for patients with stage IA-B carcinoma of the cervix? Cancer 1999;86:2273-2279.
45. Shusterman S, Meadows AT. Long term survivors of childhood leuke-mia. Curr Opin Hematol 2000;7:217-222.
46. Zanetta G, Bonazzi C, Cantu M, et al. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol. 2001;19:1015-1020.
47. Wallace W, Thomson A. Preservation of fertility in children treated for cancer. Arch Dis Child 2003;88:493-496.
48. Ataya K, Rao LV, Lawrence E and Kimmel R. Luteinizing hormonere-leasing hormone agonist inhibits cyclophosphamide-induced ovarian follicular depletion in rhesus monkeys. Biol Reprod. 1995;52:365-372.
49. Ataya K, Pydyn E, Ramahi-Ataya A and Orton CG. Is radiation induced ovarian failure in rhesus monkeys preventable by luteinizing hor-mone-releasing hormone agonists: Preliminary observations. J Clin En-docrinol Metab. 1995;8:790-795.
50. Waxman JH, Ahmed R, Smith D et al. Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemother Pharmacol. 1987;19:159-162.
51. Blumenfeld Z, Avivi I, Linn S et al. Prevention of irreversible chemo-therapy-induced ovarian damage in young women with lymphoma by a gonadotrophin-releasing hormone agonist in parallel to chemotherapy. Hum Reprod. 1996;11:1620-1626.
52. Oktay K, Sönmezer M, Oktem O, Fox K, Emons G, Bang H. Absence of conclusive evidence for the safety and efficacy of gonadotropin-releasing hormone analogue treatment in protecting against chemothera-py-induced gonadal injury. Oncologist. 2007;12(9):1055-66.
53. Clough KB, Goffinet F, Labib A, et al. Laparoscopic unilateral ovarian transposition prior to irradiation: Prospective study of 20 cases. Cancer. 1996;77:2638-2645.
54. Covens AL, van der Putten HW, Fyles AW, et al. Laparoscopic ovarian transposition. Eur J Gynaecol Oncol. 1996;17:177-182.
55. Visvanathan DK, Cutner AS, Cassoni AM, et al. A new technique of laparoscopic ovariopexy before irradiation. Fertil Steril. 2003;79:1204-1206.
56. Zinger M, Liu JH, Husseinzadeh N, et al. Successful surrogate pregnancy after ovarian transposition, pelvic irradiation and hysterectomy. J Re-prod Med 2004;49:573-574.
57. West ER, Zelinski MB, Kondapalli LA et al. Preserving female fertility following cancer treatment: current options and future possibilities. Pe-diatr Blood Cancer. 2009;53(2):289-295.
58. Stern CJ, Toledo MG, Gook DA, et al. Fertility preservation in female oncology patients. Aust NZ J Obstet Gynaecol. 2006;46:15-23.
59. Pena JE, Chang PL, Chan LK, et al. Supraphysiological estradiol levels do not affect oocyte and embryo quality in oocyte donation cycles. Hum Reprod. 2002; 17:83-87.
60. Senn A, Vozzi C, Chanson A, De Grandi P and Germond M. Prospective randomized study of two cryopreservation policies avoiding embryo selection: the pronucleate stage leads to a higher cumulative delivery rate than the early cleavage stage. Fertil Steril. 2000;74:946-952.
61. Wang JX, Yap YY and Matthews CD. Frozen-thawed embryo transfer: influence of clinical factors on implantation rate and risk of multiple conception. Hum Reprod. 2001;16:2316-2319.
62. Son WY, Yoon SH, Yoon HJ, Lee SM and Lim JH. Pregnancy outcome following transfer of human blastocysts vitrified on electron microscopy grids after induced collapse of the blastocoele. Hum Reprod. 2003;18:137-139.
63. Baka SG, Toth TL, Veeck LL, et al. Evaluation of the spindle apparatus of in-vitro matured human oocytes following cryopreservation. Hum Re-prod. 1995;10:1816-1820.
64. Gosden RG. Prospects for oocyte banking and in vitro maturation. J Natl Cancer Inst Monogr. 2005;34:60-63.
65. Kuwayama M, Vajta G, Kato O, et al. Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online. 2005;11:300-308.
66. Borini A, Sciajno R, Bianchi V, et al. Clinical outcome of oocyte cryo-preservation after slow cooling with a protocol utilizing a high sucrose concentration. Hum Reprod. 2006;21:512-517.
67. Son WY, Tan SL. Laboratory and embryological aspects of hCG-primed in vitro maturation cycles for patients with polycystic ovaries. Hum Re-prod Update. 2010;16(6):675-89.
68. Tulandi T, Huang JY, Tan SL. Preservation of female fertility: an essential progress. Obstet Gynecol. 2008;112(5):1160-72.
69. Ata B, Shalom-Paz E, Chian RC, Tan SL. In vitro maturation of oocytes as a strategy for fertility preservation. Clin Obstet Gynecol. 2010;53(4):775-86.
70. Shah DK, Goldman E, Fisseha S. Medical, ethical, and legal considera-tions in fertility preservation. Int J Gynaecol Obstet. 2011;115(1):11-5.
71. Chian RC, Huang JY, Gilbert L, Son WY, Holzer H, Cui SJ, et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril. 2009;91(6):2391-8.
72. Donnez J, Silber S, Andersen CY, Demeestere I, Piver P, Meirow D, Pellicer A, Dolmans MM. Children born after autotransplantation of cryopreserved ovarian tissue. a review of 13 live births. Ann Med. 2011;43(6):437-50.
73. Friedman O, Orvieto R, Fisch B, Felz C, Freud E, Ben-Haroush A, Abir R. Possible improvements in human ovarian grafting by various host and graft treatments. Hum Reprod. 2012;27(2):474-82.
74. Abir R, Fisch B, Jessel S, Felz C, Ben-Haroush A, Orvieto R. Improving posttransplantation survival of human ovarian tissue by treating the host and graft. Fertil Steril. 2011;95(4):1205-10.
75. Dolmans MM, Marinescu C, Saussoy P, Van Langendonckt A, Amorim C, Donnez J. Reimplantation of cryopreserved ovarian tissue from pa-tients with acute lymphoblastic leukemia is potentially unsafe. Blood. 2010;116(16):2908-14.
76. Bittinger SE, Nazaretian SP, Gook DA, Parmar C, Harrup RA, Stern CJ. Detection of Hodgkin lymphoma within ovarian tissue. Fertil Steril. 2011;95(2):803. e3-6.
77. Meirow D, Hardan I, Dor J, Fridman E, Elizur S, Ra'anani H, Slyusarev-sky E, Amariglio N, Schiff E, Rechavi G, Nagler A, Ben Yehuda D. Searching for evidence of disease and malignant cell contamination in ovarian tissue stored from hematologic cancer patients. Hum Reprod. 2008;23(5):1007-13.
78. Kyono K, Doshida M, Toya M, Sato Y, Akahira J, Sasano H. Potential indications for ovarian autotransplantation based on the analysis of 5,571 autopsy findings of females under the age of 40 in Japan. Fertil Steril. 2010 May 1;93(7):2429-30.
79. Latham KE, Wigglesworth K, McMenamin M, Eppig JJ. Stage-dependent effects of oocytes and growth differentiation factor 9 on mouse granulosa cell development: advance programming and subsequent control of the transition from preantral secondary follicles to early antral tertiary folli-cles. Biol Reprod. 2004;70(5):1253-62.
80. O'Brien MJ, Pendola JK, Eppig JJ. A revised protocol for in vitro devel-opment of mouse oocytes from primordial follicles dramatically im-proves their developmental competence. Biol Reprod. 2003;68(5):1682-6.
81. Hawkins MM, Draper GJ, Smith RA. Cancer among 1,348 offspring of survivors of childhood cancer. Int J Cancer. 1989;43(6):975-978
82. Schover LR, Agarwal A, Thomas AJ Jr. Cryopreservation of gametes in young patients with cancer. J Pediatr Hematol Oncol. 1998;20(5):426-428
83. Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005;83(6):1622-8.
84. Boldt J. Current results with slow freezing and vitrification of the human oocyte. Reprod Biomed Online. 2011;23(3):314-22.
85. Domar AD, Clapp D, Slawsby E et al. The impact of group psychological interventions on distress in infertile women. Health Psychol. 2000;19:568-575.
86. McQueeney DA, Stanton AL, Sigmon S. Efficacy of emotion-focused and problem-focused group therapies for women with fertility problems. J Behav Med, 1997;20:313-331.
87. Stewart DE, Boydell KM, McCarthy K. A prospective study of the effec-tiveness of brief professionally-led support groups for infertility patients. Int J Psychiatry Med. 1992;22:173-182.
88. Ethics Committee of the American Society for Reproductive Medicine. Fertility preservation and reproduction in cancer patients. Fertil Steril. 2005;83(6):1622-8.
89. Committee on Bioethics, American Academy of Pediatrics. Informed consent, parental permission, and assent in pediatric practice. Pediatrics. 1995;95(2):314-7.
90. Davis v. Davis, 842 S.W.2d 588, 597, 1992.
91. Pennings G, de Wert G, Shenfield F, Cohen J, Devroey P. ESHRE Task Force on Ethics and Law 11: Posthumous assisted reproduction. Hum Reprod. 2006;21(12):3050-3.
92. Chuai Y, Gao F, Li B, Zhao L, Qian L, Cao F, Wang L, Sun X, Cui J, Cai J. Hydrogen-rich saline attenuates radiation-induced male germ cell loss in mice through reducing hydroxyl radicals. Biochem J. 2012;442:49-56.